Omnipod Sales Soar, But Insulet's Outlook Cut Sparks Stock Selloff
Insulet Corp. (NASDAQ: PODD ) stock traded lower Wednesday after the insulin pump maker reported second-quarter results that topped Wall Street expectations but lowered its full-year revenue guidance and issued third-quarter sales guidance that came in below analysts’ estimates. Adjusted earnings rose to $1.66 per share from $1.17 a year earlier, beating the analyst consensus estimate of $1.45. Revenue increased 23.5% year over year to $801.7 million, topping the Street estimate of $787.2 million. Net income climbed to $95 million, or $1.37 per diluted share, from $22.5 million, or 32 cents per share, in the prior-year period. Omnipod Sales Drive Strong Quarter Total Omnipod revenue increased 24.6% to $795.9 million. U.S. Omnipod revenue rose 20.1% to $544.1 million, while international Omnipod revenue jumped 35.5% to $251.8 million. Drug Delivery revenue declined to $5.8 millio...
Insulet Corp. (NASDAQ: PODD ) stock traded lower Wednesday after the insulin pump maker reported second-quarter results that topped Wall Street expectations but lowered its full-year revenue guidance and issued third-quarter sales guidance that came in below analysts’ estimates. 45. 2 million.
5 million, or 32 cents per share, in the prior-year period. 9 million. S. 8 million.
2 million a year earlier. 7%. 3% of revenue. During the quarter, Insulet expanded Omnipod 5 into Spain, making it available in its 20th country, launched a next-generation algorithm for its automated insulin delivery system, and presented new data supporting its Omnipod 6 and fully closed-loop technology pipeline at the American Diabetes Association’s 2026 Scientific Sessions.
“We delivered another quarter of broad-based growth, robust margin expansion, and positive free cash flow,” CEO Ashley McEvoy said. She added that while the company is updating its outlook based on what it is learning as it expands in the Type 2 diabetes market, its long-term growth opportunity remains unchanged. 1 million at the end of 2025. 4 million.
5 million. 33 billion. 32 billion. 43.
58 during premarket trading on Wednesday, according to Pro data. Photo courtesy of Insulet Read Also: 'The Big Short' Investor Michael Burry Holds His Ground on Nvidia, Tesla and Other Shorts— Warns Of 1987-Style Crash: 'It Is Possible We Are Near…'